Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity
Brand: Sisters Media, LLC
Categories: Books, Medical Books, Medicine



Dimensions: 7 x 1.06 x 10 inches
Language: English
ISBN-10: 0997319615
Print length: 470 pages
Publication date: March 15, 2016
ISBN-13: 978-0997319613
Edition: 1st
subtitle: 1st Edition
author: Lawrence B. Afrin M.D. Kendra Neilsen Myles Kristi Posival
review: Editorial Reviews Review A long overdue book competently written by one of the worldwide leading hematologists in the field of systemic mast cell diseases. In addition to the current state of knowledge about systemic mast cell activation disease, the author vividly illustrates a selection of possible clinical phenotypes of this disease by means of patient cases, emphasizing the many pitfalls in diagnosis and therapy. The book is an absolute must for all physicians (the frequency of systemic mast cell activation disease in the population amounts to about 10%) and affected patients. The author s brilliant style of writing makes reading a pleasure. --GERHARD J. MOLDERINGS, M.D., Associate Professor of Pharmacology and Toxicology, Molecular Geneticist, Mast Cell Immunologist, University Hospital of Bonn, Germany Dr. Afrin's case studies illustrate how a single underlying disease process can explain a multitude of seemingly unrelated symptoms. This discovery has the potential to unlock some of the most perplexing medical mysteries of our time. His treatment protocols have ended years of patient suffering and offer much needed hope to the chronic illness community. --JENNIFER ROBIN KULIK, Founder, Mast Movement About the Author Dr. Afrin earned a B.S. in computer science at Clemson University in 1984 and then an M.D. at the Medical University of South Carolina (MUSC) in 1988, where he also pursued internal medicine residency and hematology/oncology clinical and research fellowships. While on faculty at MUSC from 1995-2014, he was active in undergraduate and graduate medical education, educational and information technology administration, and practice and research in hematology/oncology and medical informatics. Since the mid- 00s, his clinical work has increasingly focused in hematology, especially mast cell disease. He joined the University of Minnesota in 2014 to further his interests in this area. He has an extensive record of peer-reviewed publications and has spoken widely in his areas of interest.